5054
Biomedical Research Support Grant. The authors also wish to thank Dr. G.D. Green for useful discussions.
This work was supported in part by the National Institute of Environmental Health Sciences (ESO-4434).
References
1. Elbein, A.D.; Molyneux, R. in "Alkaloids; Chemical and Biological Perspectives." Vol. 5. S.W. Pelletier,
Ed., John Wiley and Sons, New York, 1987, p. 1.
2. a) Sunkara, P.S.; Bowlin, T.L.; Liu, P.S.; Sjoerdsma, A. Biochem. Biophys. Res. Commun. 1987, 148,
206. b) Lucocq, J.M.; Brada, D.; Roth, J. J. Cell. BioL 1986, 102, 2137. c) Granato, D.; Neeser, J.-R. Mol.
InvnunoL 1987, 24, 849. d) Walker, B.; Kowaski, M.; Goh, W.C.; Kozarsky, K.; Kreiger, M.; Rosen, C.;
Rohrscheider, L.; Haseltine, M.S.; Sodroski, J. Proc. Nat. Acad. Sci. 1987, 84, 8120.
3. Howard, A.S.; Michael, J.P. in "The Alkaloids; Chemistry and Pharmacology." Vol. 28, A. Brossi, Ed.,
Academic Press, Orlando, 1986, p. 183.
4. a) Arseniyadis, S.; Huang, P.Q.; Husson, H.-P. Tetrahedron Lett. 1988, 29, 631. b) Hua, D.H.; Bharathi,
S.N.; Takusagawa, F.; Tsujimoto, A.; Panangadan, J.A.K.; Hung, M.-H.; Bravo, A.A.; Erpelding, A.M.J.
Org. Chem. 1989, 54, 5659. c) Hua, D.H.; Bharathi, S.N.; Robinson, P.D.; Tsujimoto, A. J. Org. Chem.
1990, 55, 2128. d) Sibi, M.P.; Christensen, J.W. Tetrahedron Lett. 1990, 31, 5689. e) Heidt, P.C.;
Bergmeier, S.C.; Pearson, W.H. Tetrahedron Lett. 1990, 31, 5441. f) Pearson, W.H.; Lin, K.-C. Tetrahedron
Lett. 1990, 31, 7571. g) Shono, T.; Matsumura, Y.; Uchida, K.; Kobayashi, H. J. Org. Chem. 1985, 50,
3243. h) Gmeiner, P.; Lerche, H. Heterocycles 1990, 31, 9. i) Gavina, F.; Costero, A.M.; Andreu, M.R.;
Carda, M.; Luis, S.V.J. Am. Chem. Soc. 1988, 110, 4017. j) Gavina, F.; Costero, A.M.; Andreu, M.R.J.
Org. Chem. 1990, 55, 434. k) Takahata, H.; Takamatsu, T.; Yamazaki, T. J. Org. Chem. 1989, 54, 4812.
5. Thompson, C.M.; Frick, J.A.J. Org. Chem. 1989, 54, 890.
6. Thompson, C.M.; Green, D.L.C.; Kubas, R. J. Org. Chem. 1988, 53, 5389.
7. Corey, E.J.; Suggs, J.W. Tetrahedron Lett. 1975, 2647.
8. For a general procedure for the addition of the dianion of 4-PSBA to imines activated by boron trifluoride
etherate see reference 6. For imine activation see: Volkmann, R.A.; Davis, J.T.; Meltz, C.N.J. Am. Chem.
Soc. 1983, 105, 5946.
9. Cis and trans assignments were made through MMX modeling (Serena Software) and ~H NMR coupling
constant (Karplus correlation) analyses.
10. llh Isolated as white crystals from methylene chloride/hexane, mp = 136-137 °C. Anal calcd, for
C21HzsNO4S: C, 65.09; H, 6.50; N, 3.61. Found: C, 64.85; H, 6.39; N, 3.55. IR; 3400 (br), 1640 cm~. ~H
NMR (CDCI~): ~ 1.09 (m, 1H), 1.24 (m, 1H), 1.56 (m, 1H), 1.73 (m, 1H), 1.93 (s, 1H), 2.26 (m, 3H), 2.75
(m, 1H), 3.21 (dt, 1H, J=2.6, 9.4 Hz), 3.35 (m, 2H), 3.67 (dt, 1H, J = 2.6, 9.4 Hz), 3.98 (d, 1H, J = 14.7
Hz), 5.25 (d, 1H, J = 14.7 Hz), 7.42 (m, 10H). ~3C NMR (CDCI3): 19.7, 27.8, 28.8, 30.1, 48.1, 53.3,
60.7(CH), 61.3(CH), 127.7, 128.7, 128.7, 129.1, 129.3, 133.9, 136.6, 169.6.
11. Bernotas, R.C.; Cube, R.V. Synth. Commun. 1990, 20, 1209.
12. Spectral and chemical properties were consistent with literature values, see 4b.
(Received in USA 22 April 1991; accepted 30 May 1991)